Capillary electrophoresis contributions to the hydromorphone metabolism in man. (Q33244326)

24 July 2017

title

Capillary electrophoresis contributions to the hydromorphone metabolism in man. (English)

1 reference

capillary electrophoresis

24 July 2017

main subject

0 references

electrophoresis

0 references

author name string

Andrea Baldacci

series ordinal

1

1 reference

24 July 2017

Wolfgang Thormann

series ordinal

2

1 reference

24 July 2017

publication date

1 June 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

27

1 reference

24 July 2017

issue

12

1 reference

24 July 2017

page(s)

2444-2457

1 reference

Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

Hydromorphone: pharmacology and clinical applications in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Clinical pharmacology of opioids for pain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

A systematic review of hydromorphone in acute and chronic pain.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

https://api.crossref.org/works/10.1002%2FELPS.200500867

1 reference

7 January 2021

Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Role of individual human cytochrome P450 enzymes in the in vitro metabolism of hydromorphone

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

LC-MS-MS analysis of hydromorphone and hydromorphone metabolites with application to a pharmacokinetic study in the male Sprague-Dawley rat.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

https://api.crossref.org/works/10.1002%2FELPS.200500867

1 reference

7 January 2021

Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Simultaneous analysis of thebaine, 6-MAM and six abused opiates in postmortem fluids and tissues using Zymark automated solid-phase extraction and gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Exploration of the metabolism of dihydrocodeine via determination of its metabolites in human urine using micellar electrokinetic capillary chromatography

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Characterization of the genetic polymorphism of dihydrocodeine O-demethylation in man via analysis of urinary dihydrocodeine and dihydromorphine by micellar electrokinetic capillary chromatography

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Head-column field-amplified sample stacking in binary system capillary electrophoresis. 2. Optimization with a preinjection plug and application to micellar electrokinetic chromatography

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Analysis of codeine, dihydrocodeine and their glucuronides in human urine by electrokinetic capillary immunoassays and capillary electrophoresis-ion trap mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Capillary electrophoresis-electrospray ionization ion trap mass spectrometry for analysis and confirmation testing of morphine and related compounds in urine

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Capillary electrophoresis and capillary electrophoresis-ion trap multiple-stage mass spectrometry for the differentiation and identification of oxycodone and its major metabolites in human urine

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Analysis of oxycodol and noroxycodol stereoisomers in biological samples by capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Narcotic antagonists. V. Stereochemistry of reactions at C-6 in 14-hydroxynoroxymorphone derivatives

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

An improved preparation of tertiary amine N-oxides

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500867

7 January 2021

Identifiers

DOI

10.1002/ELPS.200500867

1 reference

24 July 2017

1 reference